PXL/HO/Cir-053/2017-18 Date: 07.09.2017
Indigenous Technology developed by ICMR
for production of Key Starting Material for TAMIFLU
To,
All the Members of Council,
Dear Sir/Madam,
We wish to inform our members that Indian Council of Medical Research (ICMR) has developed a technology indigenously to produce Shikmic Acid, a Key Starting Material for manufacturing TAMIFLU. A brief note on the technology developed by ICMR is enclosed herewith for information of members.
As members are aware, Government of India is keen to reduce dependency on imports of APIs, Intermediates, and Key Starting Materials. Consultations among CSIR Laboratories, industry and other stakeholders are going on to formulate strategies to reduce import dependency and make Indian pharma industry self-sufficient.
In the light of above developments, manufacturers of APIs, Intermediates/KSMs may like to avail the technology developed by ICMR for manufacturing KSM for Tamiflu
Interested members may directly contact ICMR or write to us at info@pharmexcil.com / ed@pharmexcil.com for onward submission to ICMR for further negotiations.
With regards
Raghuveer Kini
Executive Director
Encl: TAMIFLU
|